Vemurafenib Induces Senescence Features In Melanoma Cells
Vemurafenib treatment of melanoma cell lines was associated with a pro-apoptotic response (Lee et al., 2010; Sondergaard et al., 2010; Tap et al., 2010), the preferred outcome of tumor therapy. However, in other tumor types, the inhibition of the driver ... Fetch Here
InPlay From Briefing.com
InPlay from Briefing.com ... Read News
Causes And treatment Of Malignant melanoma - Nursing Times
Treatment of malignant melanoma. Nursing Times; 109: 28, 12-15. The incidence of melanoma is rising faster than any other malignancy. As more cases Vemurafenib Vemurafenib (Zelboraf) has recently been approved by the National Institute for ... Fetch Content
MediaPharm - Malignant Melanoma Therapy Gets Personal ...
The new FDA approved drug vemurafenib (Zelboraf) is offering hope for personalized treatment of one of the hardest to treat cancers. Why do I say this treatment is personalized? Check out the podcast with Dr Dean Elbe to find out. ... View Video
Vemurafenib And Ipilimumab: New Agents For Metastatic melanoma
This article reviews two new agents for treatment of metastatic melanoma. Vemurafenib (vem′′ ue raf′ e nib) (Zelboraf, Hoffmann-La vemurafenib treatment. The overall survival rate, evaluated at 6 months in 672 patients, was 84% ... Document Retrieval
FDA Approves Zelboraf (vemurafenib) And Companion Diagnostic ...
4/5 results, allowing doctors to know whether a person with metastatic melanoma is eligible for treatment with Zelboraf. About Zelboraf Zelboraf is an oral, small molecule, kinase inhibitor indicated for the treatment of patients with unresectable ... Content Retrieval
Dr. Antoni Ribas On Combining Vemurafenib And Ipilimumab For ...
Antoni Ribas, MD, Department of Medicine, Division of Hematology-Oncology; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), describes a phase I/II trial that plans to combine the BRAF inhibitor vemurafenib (Zelboraf) and the cytotoxic T ... View Video
Treatment Of Metastatic Malignant Melanoma With Vemurafenib ...
Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy Introduction The prognosis of stage IV malignant melanoma (MM) has for ... Doc Viewer
Kolltan Pharmaceuticals Presents KTN3379 Preclinical Data At The AACR-NCI-EORTC International Conference On Molecular ...
Kolltan Pharmaceuticals, Inc., a privately held clinical-stage company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases , today announced the presentation of preclinical data showing that KTN3379 reverses ErbB3-mediated resistance of BRAF and MEK inhibitors in BRAF-mutated thyroid cancer and melanoma. ... Read News
Ruptured Hepatic Metastases Of Cutaneous melanoma During ...
CASE REPORT Open Access Ruptured hepatic metastases of cutaneous melanoma during treatment with vemurafenib: an autopsy case report Takuto Nosaka1, Katsushi Hiramatsu1, Tomoyuki Nemoto1, Yasushi Saito1, Yoshihiko Ozaki1, Kazuto Takahashi1, ... Get Content Here
A STATement On vemurafenib-resistant melanoma.
A STATement on vemurafenib-resistant melanoma. Edward J Hartsough Thomas Jefferson University, edward.hartsough@jefferson.edu In addition, combined treatment with vemurafenib and WP1066 decreased the number of vemurafenib-resistant cells more effectively than either drug alone. ... Access Doc
No comments:
Post a Comment